Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Pre-exposure prophylaxis for HIV prevention: how to predict success.

Kashuba AD, Patterson KB, Dumond JB, Cohen MS.

Lancet. 2012 Jun 30;379(9835):2409-11. doi: 10.1016/S0140-6736(11)61852-7. Epub 2011 Dec 6. No abstract available.

2.

Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.

Castel AD, Magnus M, Greenberg AE.

Infect Dis Clin North Am. 2014 Dec;28(4):563-83. doi: 10.1016/j.idc.2014.08.001. Epub 2014 Nov 20. Review.

PMID:
25455314
3.

NHS to fund large trial of pre-exposure prophylaxis for HIV prevention.

Mayor S.

BMJ. 2016 Dec 5;355:i6537. doi: 10.1136/bmj.i6537. No abstract available.

PMID:
27919905
4.

What is the place of pre-exposure prophylaxis in HIV prevention?

De Man J, Colebunders R, Florence E, Laga M, Kenyon C.

AIDS Rev. 2013 Apr-Jun;15(2):102-11. Review.

PMID:
23685443
5.

Highlights from the 23rd CROI.

Hayward P.

Lancet Infect Dis. 2016 Apr;16(4):413. doi: 10.1016/S1473-3099(16)00141-9. No abstract available.

PMID:
27036347
6.

Pre-exposure prophylaxis for South African adolescents: What evidence?

Bekker LG, Gill K, Wallace M.

S Afr Med J. 2015 Nov;105(11):907-11. doi: 10.7196/SAMJ.2015.v105i11.10222. Review.

PMID:
26632316
7.

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.

Derdelinckx I, Wainberg MA, Lange JM, Hill A, Halima Y, Boucher CA.

PLoS Med. 2006 Nov;3(11):e454. Review. No abstract available.

8.

Pre-exposure prophylaxis protects against HIV infection in real world setting, study finds.

Kmietowicz Z.

BMJ. 2015 Feb 25;350:h1076. doi: 10.1136/bmj.h1076. No abstract available.

PMID:
25716462
9.

Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.

Grangeiro A, Couto MT, Peres MF, Luiz O, Zucchi EM, de Castilho EA, Estevam DL, Alencar R, Wolffenbüttel K, Escuder MM, Calazans G, Ferraz D, Arruda É, Corrêa Mda G, Amaral FR, Santos JC, Alvarez VS, Kietzmann T.

BMJ Open. 2015 Aug 25;5(8):e009021. doi: 10.1136/bmjopen-2015-009021.

10.

Antiretroviral drugs for pre-exposure prophylaxis of HIV infection.

Fernández-Montero JV, Barreiro P, Del Romero J, Soriano V.

AIDS Rev. 2012 Jan-Mar;14(1):54-61. Review.

PMID:
22297504
11.

Untangling the cost-effectiveness knot: who is oral antiretroviral HIV pre-exposure prophylaxis really for?

Hankins CA.

Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):167-70. doi: 10.1586/14737167.2014.887447. Epub 2014 Feb 19.

PMID:
24552641
12.

Predictors of pregnancy in microbicide trials.

Halpern V, Lie CC, Feldblum P, Van Damme L; Microbicide Research Group.

Contraception. 2011 May;83(5):436-40. doi: 10.1016/j.contraception.2010.08.018. Epub 2010 Oct 8.

PMID:
21477686
13.

'Less education' is associated with use and sharing of antiretroviral medications for prophylaxis of HIV infection by US men who have sex with men.

Mansergh G, Koblin B, Colfax GN, Flores SA, Hudson SM; Project MIX Study Team.

Sex Transm Infect. 2011 Oct;87(6):510. doi: 10.1136/sextrans-2011-050188. Epub 2011 Aug 26. No abstract available.

PMID:
21873470
14.

Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis.

Tissot F, Erard V, Dang T, Cavassini M.

HIV Med. 2010 Oct 1;11(9):584-92. doi: 10.1111/j.1468-1293.2010.00826.x. Epub 2010 Mar 25.

15.

[Antiretroviral prophylaxis after non-occupational exposure to HIV in Abidjan (Cote d'Ivoire)].

Ehui E, Tanon A, Guié P, Aba T, Toa-Lou C, Kassi A, Ouattara I, Kouakou G, Mossou C, Kakou A, Eholié S, Aoussi E, Bissagnéné E.

Med Mal Infect. 2010 Oct;40(10):574-81. doi: 10.1016/j.medmal.2010.04.008. French.

PMID:
20554137
16.

Beyond "getting drugs into bodies": social science perspectives on pre-exposure prophylaxis for HIV.

Auerbach JD, Hoppe TA.

J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):19983. doi: 10.7448/IAS.18.4.19983. eCollection 2015.

17.

The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.

Chua A, Ford N, Wilson D, Cawthorne P.

PLoS Med. 2005 Oct;2(10):e346. Epub 2005 Oct 25. No abstract available.

18.

Pre-Exposure Prophylaxis as a Method for Prevention of Human Immunodeficiency Virus Infection.

Elbirt D, Mahlab-Guri K, Bezalel-Rosenberg S, Asher I, Sthoeger Z.

Isr Med Assoc J. 2016 May;18(5):294-8. Review. No abstract available.

19.

Tribulations and trials in HIV disease, Part I.

Boyle BA.

AIDS Read. 2006 May;16(5):240-4. No abstract available.

PMID:
16764065
20.

Preventing HIV infection: pre-exposure and postexposure prophylaxis.

Doblecki-Lewis S, Kolber MA.

IUBMB Life. 2014 Jul;66(7):453-61. doi: 10.1002/iub.1286. Epub 2014 Jun 27. Review.

Supplemental Content

Support Center